Effect of Gammalinolenic acid in hand eczema
Phase 3
Recruiting
- Conditions
- Hand eczema.Disease of the skin and subcutaneous tissue
- Registration Number
- IRCT20201101049215N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 52
Inclusion Criteria
Chronic or subacute hand eczema, unilateral or bilateral
Exclusion Criteria
Acute hand eczema
pregnant or lactating women
Use systemic immunosuppressant drug for one recent month
Use topical therapies for hand eczema for two recent weeks
To have localized infection in hands
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Han Eczema Severity Score and Dermatology Life Quality Score. Timepoint: First visit and after one month of drug use. Method of measurement: measurement table of hand eczema severity index and questionnaire of dermatologiy life quality index.
- Secondary Outcome Measures
Name Time Method